Western Wealth Management, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1767902 GOLDEN, CO

Position in VRTX

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$728,306

+$443,596 QoQ

Shares Held

1,631

+159.7% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Western Wealth Management, LLC holds $2,047,390 across 53 Biotechnology names. VRTX ranks #1 (35.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,631	$728,306
2	AUPH	Aurinia Pharmaceuticals Inc.	20,317	$301,097
3	HALO	Halozyme Therapeutics, Inc.	3,545	$229,112
4	DAWN	Day One Biopharmaceuticals, Inc.	8,005	$171,627
5	VKTX	Viking Therapeutics, Inc.	3,115	$101,362
6	CRSP	CRISPR Therapeutics AG	1,967	$93,570
7	STOK	Stoke Therapeutics, Inc.	1,700	$55,352
8	CYTK	Cytokinetics Inc	800	$52,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$728,306	1,631	+159.7%	Shares	Sole	2026-05-19
2025-12-31	$284,710	628	+9.0%	Shares	Sole	2026-02-05
2025-09-30	$225,584	576	-7.2%	Shares	Sole	2025-11-06
2025-06-30	$276,469	621	-10.1%	Shares	Sole	2025-08-11
2025-03-31	$335,010	691	-16.0%	Shares	Sole	2025-04-23
2024-12-31	$331,422	823	-21.8%	Shares	Sole	2025-02-18
2024-09-30	$489,264	1,052	+11.1%	Shares	Sole	2024-11-12
2023-12-31	$385,324	947	+4.8%	Shares	Sole	2024-01-31
2023-09-30	$314,356	904	-6.5%	Shares	Sole	2023-11-08
2023-06-30	$340,296	967	+33.9%	Shares	Sole	2023-08-30
2022-09-30	$209,047	722	-27.0%	Shares	Sole	2022-11-07
2022-03-31	$258,099	989	—	Shares	Sole	2022-05-10
No filing history on record for this holder in this stock.